Key result
Whole-heart irradiation triggers a sustained stromal-immune inflammatory cascade driving radiation-induced heart injury.
Why the study?
Radiation-induced heart injury is a major late toxicity of thoracic radiotherapy, but the cellular and molecular mechanisms driving its progression remain poorly defined.
Single-cell transcriptomics reveals that radiation-induced heart injury is driven by a stromal-immune cascade, highlighting non-hematopoietic antigen presentation as a potential therapeutic target.
scRNA-seq maps cell-type-specific changes in irradiated rat hearts; leaves open translation to human RIHI mechanisms or therapies.
Background: Radiation-induced heart injury (RIHI) is a major late toxicity of thoracic radiotherapy, yet the cellular and molecular mechanisms driving its progression remain poorly defined. Methods: Single-cell RNA sequencing (scRNA-seq) was performed on rat hearts and matched peripheral blood mononuclear cells (PBMCs) 12 weeks after whole-heart irradiation (20 Gy) or sham control, profiling 38,941 cardiac cells across 15 types and 41,097 PBMCs across 9 types. Differential expression, pathway enrichment, pseudotime, and ligand-receptor interaction analyses were conducted. Key findings in endothelial cells and fibroblasts were validated by Western blotting and flow cytometry. Results: Major cardiac populations, including cardiomyocytes, endothelial cells (ECs), fibroblasts, neutrophils, macrophages, T cells, NK cells, and B cells, were defined in control and RIHI hearts. Following irradiation, ECs showed distinct subtype shifts with marked MHC-II upregulation, while fibroblasts exhibited iron accumulation, pro-inflammatory activation, and antigen-presenting properties. These stromal alterations coincided with myeloid activation (macrophage and IL-1β⁺ neutrophil programs) and T/NK cell polarization toward cytotoxic yet partially exhausted states, together with enhanced B-cell antigen presentation. Collectively, these findings delineate a stromal-immune cascade linking radiation injury to chronic cardiac inflammation. Conclusion: RIHI progresses through a stromal-immune cascade where EC and fibroblast immunogenic reprogramming initiates sustained myeloid and lymphoid activation, creating a pro-inflammatory cardiac microenvironment. These findings highlight non-hematopoietic antigen presentation as a therapeutic target in thoracic radiotherapy, particularly when combined with immune checkpoint inhibitors.
No takes yet. Share an insight, caveat, or question.
Yan et al. (2026) studied Radiation-induced heart injury (n=3). Whole-heart irradiation vs. Sham control was evaluated on Cellular and molecular mechanisms of radiation-induced heart injury via scRNA-seq. Whole-heart irradiation in rats induced a stromal-immune cascade characterized by endothelial and fibroblast immunogenic reprogramming, sustained myeloid and lymphoid activation, and a pro-inflammatory cardiac microenvironment.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: